Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Infectious Disease: early-phase trial registry
8 of 19 indexed Infectious Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 8 currently recruiting · #902 of 28,707 conditions by registered trial count
Infectious Disease: 19 US clinical trials tracked, 8 recruiting.
Infectious Disease is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Immorna Biotherapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition infectious-disease
OPEN 8 | RECR 42% | LATE 0 | EARLY 4 | RANK #902 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Brain Concussion (42% recruiting · 19 trials)
Infectious Disease lists 8 open slots (42% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Infectious Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Infectious Disease is recruiting below its size-band peers.
8 of 19 indexed trials (42.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Infectious Disease trials is spread across many organizations.
Immorna Biotherapeutics accounts for 2 of 19 trials (10.5%). 17 distinct sponsors appear on at least one study for this condition label.
-
Typical Infectious Disease enrolment sits around 273 participants.
Median target enrolment is 273 among the 19 trials that report a genuine target (sentinel values excluded). 6 of those (31.6%) plan for fewer than 100 participants.
-
Infectious Disease splits between interventional and observational designs.
12 interventional and 7 observational studies make up this index (63.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
AnovaOS Network Powered Patient Registry
Anova Enterprises
NCT05013944
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen
NCT03848962
Triage Survey for Infectious Disease Eligibility
Brooklyn Clinical Research
NCT06492187
Compliant Analysis of Patient Samples and Data
Sequenom
NCT04364503
An International Observational Study of Adults With Acute Infection
University of Minnesota
NCT07069400
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
Mount Sinai Hospital, Canada
NCT06004739
Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
The University of Queensland
NCT06510699
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
University of California, San Francisco
NCT05286203
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
Yale University
NCT05286879
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Immorna Biotherapeutics
NCT06564194
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
Brigham and Women's Hospital
NCT04796285
Minnesota COVID-19 Testing Project
Harvard University
NCT04568889
University of Utah COVID-19 Hydrochloroquine Trial
University of Utah
NCT04342169
Clinical Decision Support Tools for Antibiotic Prescribing
Beth Israel Deaconess Medical Center
NCT03580603
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
Medical University of South Carolina
NCT02638298
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Immorna Biotherapeutics
NCT05871541
Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic
Medical University of South Carolina
NCT01861457
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
George Washington University
NCT05063812
Implementation of CareCube Negative Pressure Isolation Units
Saint Luke's Health System
NCT05229926
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Infectious Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Infectious Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Infectious Disease page
19 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Infectious Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Immorna Biotherapeutics sponsors the most Infectious Disease trials on record, review their full trial history before evaluating a specific study. See Immorna Biotherapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infectious Disease condition card totals 19 registered trials; most-linked intervention Placebo; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.